Inhibition of PKC Epsilon Attenuates Cigarette Smoke Extract-Induced Apoptosis in Human Lung Fibroblasts (MRC-5 Cells).
- Author:
Shin Myung KANG
1
;
Jin Young YOON
;
Yu Jin KIM
;
Sang Pyo LEE
;
Sung Hwan JEONG
;
Jeong Woong PARK
Author Information
- Publication Type:Original Article
- Keywords: Apoptosis; Cigarette Smoking; Protein Kinase C-epsilon
- MeSH: Apoptosis; Benzimidazoles; Blotting, Western; Caspase 3; Caspase 8; Cell Death; Cell Line; Cell Membrane; Cell Survival; Fibroblasts; Flow Cytometry; Humans; L-Lactate Dehydrogenase; Lung; Lung Diseases; Membranes; Protein Kinase C; Protein Kinase C-epsilon; Pulmonary Disease, Chronic Obstructive; Smoke; Smoking; Tobacco Products
- From:Tuberculosis and Respiratory Diseases 2011;71(2):88-96
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: It is known that cigarette smoke (CS) causes cell death. Apoptotic cell death is involved in the pathogenesis of CS-related lung diseases. Some members of the protein kinase C (PKC) family have roles in cigarette smoke extract (CSE)-induced apoptosis. This study was conducted to investigate the role of PKC epsilon in CSE-induced apoptosis in human lung fibroblast cell line, MRC-5. METHODS: Lactate dehydrogenase release was measured using a cytotoxicity detection kit. The MTT assay was used to measure cell viability. Western immunoblot, Hoechst 33342 staining and flow cytometry were used to demonstrate the effect of PKCepsilon. Caspase-3 and caspase-8 activities were determined using a colorimetric assay. To examine PKCepsilon activation, Western blotting was performed using both fractions of membrane and cytosol. RESULTS: We showed that CSE activated PKCepsilon by demonstrating increased expression of PKCepsilon in the plasma membrane fraction. Pre-treatment of PKCepsilon peptide inhibitor attenuated CSE-induced apoptotic cell death, as demonstrated by the MTT assay (13.03% of control, 85.66% of CSE-treatment, and 53.73% of PKCepsilon peptide inhibitor-pre-treatment, respectively), Hoechst 33342 staining, and flow cytometry (85.64% of CSE-treatment, 53.73% of PKCepsilon peptide inhibitor-pre-treatment). Pre-treatment of PKCepsilon peptide inhibitor reduced caspase-3 expression and attenuated caspase-3, caspase-8 activity compared with CSE treatment alone. CONCLUSION: PKCepsilon seem to have pro-apoptotic function and exerts its function through the extrinsic apoptotic pathway in CSE-exposed MRC-5 cells. This study suggests that PKCepsilon inhibition may be a therapeutic strategy in CS-related lung disease such as chronic obstructive pulmonary disease.
